In their novel research paper titled “Ultrasonic assessment of the effects of self-assembling peptide scaffolds on preventing enamel demineralization”, the Japanese research group of Prof. Miyazaki has shown that CURODONT™ REPAIR can promote remineralisation and inhibit demineralisation of teeth, indicating a clear benefit for patients receiving the treatment.
The researchers from the Department of Operative Dentistry at Nihon University used Ultrasonic Velocity measurements together with Scanning Electron Microscopy and 3-D Laser Scanning Microscopy to show that CURODONT™ REPAIR can inhibit demineralisation and promote remineralisation of teeth. In addition it was shown that the teeth treated with CURODONT™ REPAIR were “covered with needle-like deposits” indicating the formation of novel hydroxyapatite (tooth mineral). The study was published in the latest issue of Acta Odontologica Scandinavia.
The researchers conclude their paper with the strong statement that “[…] the influence of [CURODONT™ REPAIR] on the promotion of enamel remineralisation, as observed in the present study, would prove to be clinically beneficial.”
Acto Odontologica Scandinavia
CURODONT REPAIR Webpage
credentis Webpage
About CURODONT™ and the CUROLOX® TECHNOLOGY
The patented CUROLOX® TECHNOLOGY is based on peptides self-assembling into a 3-dimensional matrix, triggering biomimetic mineralisation and repair. The core technology is the basis for all innovative credentis products.
CURODONT™ REPAIR provides dentists with a non-invasive option for natural in-depth mineralisation or Guided Enamel Regeneration (GER) which enables the regeneration of caries lesions and similar defects. Applied to an early lesion, CURODONT™ REPAIR forms a scaffold within the lesion to guide new hydroxyapatite (tooth mineral) crystals to form and grow. Ideally, the caries is stopped and the lesion will mineralise within several weeks.
CURODONT™ PROTECT uses the CUROLOX® TECHNOLOGY to protect the tooth surface from acid attack. CURODONT™ D’SENZ is optimised for the treatment of dentine hypersensitivity, to be used before dental hygiene treatment or in conjunction with tooth bleaching.
With its regenerative product line, credentis supports the trend towards prevention and early treatment. The ultimate goal is to prevent caries through the use of its regenerative solutions and frequent recalls by dentists and hygienists.
About credentis ag
credentis ag is headquartered in the Technopark Aargau, Switzerland. credentis has won multiple awards as well as support from organizations such as Genilem. Public grants include Swiss National Science Foundation (SNF), Aargauer Forschungsfonds in collaboration with the FHNW School of Life Sciences in Muttenz and the Medical Technologies IKC (in co-operation with the University of Leeds).
Dr. Dominik Lysek, CEO and Michael Hug, CTO have a strong track record in science, development and medical technology, with focus in the dental industry. credentis board members Dr. Werner Berner, Dr. Michael Peetz, Gerard Moufflet and Dr. Erich Platzer (chairman), contribute their pharma, medtech and dental industry expertise.
The researchers from the Department of Operative Dentistry at Nihon University used Ultrasonic Velocity measurements together with Scanning Electron Microscopy and 3-D Laser Scanning Microscopy to show that CURODONT™ REPAIR can inhibit demineralisation and promote remineralisation of teeth. In addition it was shown that the teeth treated with CURODONT™ REPAIR were “covered with needle-like deposits” indicating the formation of novel hydroxyapatite (tooth mineral). The study was published in the latest issue of Acta Odontologica Scandinavia.
The researchers conclude their paper with the strong statement that “[…] the influence of [CURODONT™ REPAIR] on the promotion of enamel remineralisation, as observed in the present study, would prove to be clinically beneficial.”
Acto Odontologica Scandinavia
CURODONT REPAIR Webpage
credentis Webpage
About CURODONT™ and the CUROLOX® TECHNOLOGY
The patented CUROLOX® TECHNOLOGY is based on peptides self-assembling into a 3-dimensional matrix, triggering biomimetic mineralisation and repair. The core technology is the basis for all innovative credentis products.
CURODONT™ REPAIR provides dentists with a non-invasive option for natural in-depth mineralisation or Guided Enamel Regeneration (GER) which enables the regeneration of caries lesions and similar defects. Applied to an early lesion, CURODONT™ REPAIR forms a scaffold within the lesion to guide new hydroxyapatite (tooth mineral) crystals to form and grow. Ideally, the caries is stopped and the lesion will mineralise within several weeks.
CURODONT™ PROTECT uses the CUROLOX® TECHNOLOGY to protect the tooth surface from acid attack. CURODONT™ D’SENZ is optimised for the treatment of dentine hypersensitivity, to be used before dental hygiene treatment or in conjunction with tooth bleaching.
With its regenerative product line, credentis supports the trend towards prevention and early treatment. The ultimate goal is to prevent caries through the use of its regenerative solutions and frequent recalls by dentists and hygienists.
About credentis ag
credentis ag is headquartered in the Technopark Aargau, Switzerland. credentis has won multiple awards as well as support from organizations such as Genilem. Public grants include Swiss National Science Foundation (SNF), Aargauer Forschungsfonds in collaboration with the FHNW School of Life Sciences in Muttenz and the Medical Technologies IKC (in co-operation with the University of Leeds).
Dr. Dominik Lysek, CEO and Michael Hug, CTO have a strong track record in science, development and medical technology, with focus in the dental industry. credentis board members Dr. Werner Berner, Dr. Michael Peetz, Gerard Moufflet and Dr. Erich Platzer (chairman), contribute their pharma, medtech and dental industry expertise.
